<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_UChile_OpenBio-CeBiB_Model_Results skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:UChile OpenBio-CeBiB/Model/Results</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Document</TITLE></P><DIV class="collapse navbar-collapse" id="navbarNavDropdown"><UL class="navbar-nav ml-auto"><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Description" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
          Project
        </A><DIV class="dropdown-menu item2" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Description">Description</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Parts">Parts</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Experiments">Procedures</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Results">Results</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Attributions">Attributions</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/HP" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
          HP
        </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/HP">HP Overview</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Collaborations">Collaborations</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/HP/Silver">Silver</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/HP/Gold_Integrated">Gold</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Engagement">Engagement</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Model" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
          Modelling
        </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Model">Modelling Overview</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Model/Procedure">Procedure</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Model/Results">Results</A></DIV></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Safety" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
          Safety
        </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Safety/Biosafety">Biosafety</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Safety/LabProtocols">Lab Protocols</A></DIV></LI><LI class="nav-item"><A class="nav-link" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Notebook">Notebook<SPAN class="sr-only">(current)</SPAN></A></LI><LI class="nav-item"><A class="nav-link" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Team">Team<SPAN class="sr-only">(current)</SPAN></A></LI><LI class="nav-item dropdown"><A class="nav-link dropdown-toggle" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Jamboree" id="navbarDropdownMenuLink" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> Giant Jamboree </A><DIV class="dropdown-menu" aria-labelledby="navbarDropdownMenuLink"><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Jamboree/OurExperience">Our experience</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Jamboree/JudgingFeedback">Judging Feedback</A><A class="dropdown-item" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB/Jamboree/Photos">Photos</A></DIV></LI><LI class="nav-item"><A class="nav-link" href="https://2017.igem.org/Team:UChile_OpenBio-CeBiB">Home<SPAN class="sr-only">(current)</SPAN></A></LI></UL></DIV><DIV class="container" style="margin-top:150px;"><H1 style="text-align:center;"> Results </H1><P>From the previous procedures, we obtained the following results: </P><H3>Phase 1: The First Approach</H3><BUTTON class="accordion" style="margin-top:30px;"><P id="panelTitle">Calvin Cycle</P></BUTTON><DIV class="panel" style="padding: 0 18px;"><DIV id="imgCont" align="center"><H4 style="margin-top:30px;">Metabolic Pathway</H4><P style="margin-top:10px;">
We observed the production of Glucose 6-phosphate, and an increased of the intermediaries affected by FBP/SBPase. Aditionally, all the compounds reach the steady state with concentrations close to reallity, but the timeline should be reviewed. We considered this model correct for a first approach.
</P><H4 style="margin-top:30px;">Genetic Pathway</H4><P>

The graphic shows the increase of FBP/SBPasa enzyme, which confirm the expected results. If we expand the timeline, we could observed the steady state.
</P></DIV></DIV><BUTTON class="accordion" style="margin-top:30px;"><P id="panelTitle">Starch Synthesis Pathway - Antisense</P></BUTTON><DIV class="panel" style="padding: 0 18px;"><DIV id="imgCont" align="center"><H4 style="margin-top:30px;">Metabolic Pathway, B12 Absent</H4><H4 style="margin-top:30px;">Metabolic Pathway, B12 Present</H4><P style="">

We observed that in absence of B12, the steady state is reached after than in the case of presence of the vitamin. Besides, in the first graph there is an initial accumulation of UDP-Glucose, which in the second scenario is null due to the full production of starch. 


</P><H4 style="margin-top:30px;">Genetic Pathway, B12 Absent</H4><H4 style="margin-top:30px;">Genetic Pathway, B12 Present</H4><P>


We observed the same behavior of STA1 and STA6 for both cases, therefore insensitive to B12 vitamin. For GBS2 we observed the expected behavior, having a null production of protein, due to the production of antisense RNA, which is confirmed with the formation of double strand DNA.

</P></DIV></DIV><H3 style="margin-top:80px;">Phase 2: Sensitivity Analysis</H3><BUTTON class="accordion" style="margin-top:30px;"><P id="panelTitle">Michaelis Menten Constant (Km)</P></BUTTON><DIV class="panel"><H4 style="margin-top:30px;">G6P Production from Calvin Cycle</H4><DIV id="imgCont" align="center"><P style="margin-top:10px; padding: 0 18px;">
For G6P production from Calvin Cycle, it is possible to highlight six Michaelis Menten constants important to consider. This process is most influenced by the F6P-G6P conversion, given it is a reversible reaction. This makes it possible to optimize the cycle in order to determine the best set of parameters to fully achieve maximum carbon uptake, which would then allow us to evaluate the possibility of including new catalysis mechanisms regarding these reactions. Additionally, we have to notice that the majority of the sensitive parameters <B>do not</B> increase the concentration of G6P in steady state given the variation of their values, but instead they actually decrease this amount. Therefore, it may occur that the upper limit of G6P production (which correlates directly to carbon fixation) is already given by the chosen set of parameters. As a summary, the key reaction is the reversible conversion of fructose-6-phosphate to glucose-6-phosphate.</P><H4 style="margin-top:30px;">Starch Production from Antisense</H4></DIV><P style="margin-top:10px; padding:0 18px;">
We can observe that the reactions concerning the molecule glucose-6-phosphate are the most sensitive for optimization. Regarding the Michaelis Menten constant of the enzymes, there was no considerable variation in the STA1/STA6 (in this case, STA denotes both enzymes). This could occur due to precision problems with the algorithm and the software sensitivity to extremely low numbers. Considering this, it is necessary to take into account the three enzyme's kinetic parameters for the subsequent optimization</P></DIV><BUTTON class="accordion" style="margin-top:30px;"><P id="panelTitle">Maximum Rate (Vmax)</P></BUTTON><DIV class="panel"><H4 style="margin-top:30px;">G6P Production from Calvin Cycle</H4><DIV id="imgCont" align="center"><P style="margin-top:10px; padding:0 18px;">
Virtually, the same conclusions from the Michaelis Menten constants of the Calvin Cycle are reached, except for the conversion of G6P-F6P, where in this case it is not absurdly more heavy in influence than the other parameters.</P><H4 style="margin-top:30px;">Starch Production from Antisense</H4><P style="margin-top:10px; padding:0 18px;">
In this case, exactly the same conclusions as the corresponding Michaelis Menten constants are drawn.</P></DIV></DIV><BUTTON class="accordion" style="margin-top:30px;"><P id="panelTitle">Other Metabolic Constants</P></BUTTON><DIV class="panel"><DIV id="imgCont" align="center"><H4 style="margin-top:30px;">G6P Production from Calvin Cycle</H4><P style="margin-top:10px; padding: 0 18px;&gt;
These are constants related to the carboxylation/oxygenation mechanism of RuBisCo. From these graphs it is possible to say that we could potentially modify these constants to an optimal value by manipulations of this enigmatic enzyme. It is recommended to any future iGEM team that wishes to achieve a similar objective (increase carbon fixation) to engineer RuBisCo mechanism.&lt;/p&gt;
&lt;h4 style=" margin-top:30px="">Starch Production from Antisense</P><P style="margin-top:30px; padding: 0 18px;">
Here we see that the degradation rate of G6P, UDPG, and Starch are the most relevant in the circuit. However, modifying these values is somewhat difficult unless an additional enzyme to increase stability of the mentioned compounds is inserted. Therefore, these parameters wouldn't be transcendental for the optimization, but their value must still be determined by model fitting.</P></DIV></DIV><BUTTON class="accordion" style="margin-top:30px;"><P id="panelTitle">Genetic Constants</P></BUTTON><DIV class="panel"><DIV id="imgCont" align="center"><H4 style="margin-top:30px;">GBS2 effect on Starch Production</H4><H4 style="margin-top:30px;">STA1 effect on Starch Production</H4><H4 style="margin-top:30px;">STA6 effect on Starch Production</H4><P style="margin-top:10px; padding:0 18px;">
It is pretty evident that the system is heavily affected by GBS2, and the other enzymes have little influence. The supposed reason was mentioned earlier: the algorithms and software may not be sensitive to low values of initial conditions, though the circuit could actually just be chaotic. Nevertheless, it is necessary to consider these parameters for the three enzymes in order to properly optimize the starch synthesis pathway control.</P></DIV></DIV></DIV></DIV></DIV></DIV></DIV></DIV></BODY></HTML>